Eminence Capital, LP Atara Biotherapeutics, Inc. Transaction History

Eminence Capital, LP

  • $6.79 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.69 - $9.84 $209,338 - $439,208
-44,635 Reduced 3.26%
1,323,075 $10.3 Million
Q1 2022

May 16, 2022
BUY
$8.44 - $16.89 $1.91 Million - $3.82 Million
226,253 Added 19.82%
1,367,710 $12.7 Million
Q4 2021

Feb 14, 2022
BUY
$14.7 - $19.89 $16.8 Million - $22.7 Million
1,141,457 New
1,141,457 $18 Million

Others Institutions Holding ATRA

# of Institutions
87
Shares Held
85M
Call Options Held
18.4K
Put Options Held
51.3K
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $728M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Eminence Capital, LP Portfolio

Follow Eminence Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eminence Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email